The Rotation of Disinfectants Principle: True or False? - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Rotation of Disinfectants Principle: True or False?
The author defines sanitizers, disinfectants, and antibiotics, and examines the question of whether the rotation of disinfectants is scientifically warranted.


Pharmaceutical Technology
Volume 33, Issue 2, pp. 58-71

Clinical microbiologists use susceptibility tests to predict the probability of an antibiotic's therapeutic success. To say that bacteria are susceptible to an antibiotic means that, under laboratory conditions, the minimum inhibitory concentration (MIC) of that antibiotic complied with the recommended standard for the target microorganism. But therapeutic success is not assured because the interactions between the host and the microorganism also influence therapeutic success.

Resistance occurs when the required amount of antibiotic exceeds the minimum MIC and the likelihood of therapeutic success is low. Reduced susceptibility to an antibiotic occurs when the recommended concentration to achieve therapeutic success is not effective and a higher concentration is required to achieve therapeutic success. When an antibiotic complies with the minimum MIC but is ineffective against an infection by a microorganism, the microorganism is said to be resistant, regardless of whether the failure was caused by the host, antibiotic, or clinician.

Classes of disinfectants and examples of resistance

Studies of disinfectants' mechanisms of action generally indicate that, unlike antibiotics, whose high levels of target-specificity facilitate selective action against specific cell targets, disinfectants work at many sites within the cell. The damage caused by disinfectants is seldom accomplished through a single injury and is a direct consequence of exposure to or chemical attack by the disinfectant's active ingredients. That is, the actions of disinfectants are, in most cases, not pharmacologically precise (1). In the case of bacteriostatic antibiotics, the host's immune response plays an important role in eradicating the invading microorganisms. Disinfectant formulations contain biocidal chemicals at concentrations high enough to affect multiple rather than unique targets. Supplementary ingredients are also included in disinfectant formulations to enhance the killing effects.

The activity of disinfectants is measured by MIC or MBC. In this sense, the antibacterial ingredient could be an antibiotic, an antiseptic, or a disinfectant. The MIC is determined by visual inspection of the media used in the test, and the MBC requires plate counts to quantify the amount of inactivated or killed microorganisms.


Table II: Oxidizing disinfectants.
Disinfectants are classified in two broad categories: oxidizing disinfectants and nonoxidizing disinfectants. These two categories are further subdivided. Tables II and III list common disinfectants (and some antiseptics) and their modes of action. These lists are not exhaustive; only the most relevant examples are presented.

Oxidizing agents


Table III: Nonoxidizing disinfectants.
As Tables II and III show, most disinfectants' mechanism of action is nonspecific and damages cells at different targets. The most effective disinfectants are oxidizing agents, followed by reducing agents.

Hydrogen peroxide. Helicobacter pylori has shown resistance to hydrogen peroxide at a use concentration of ~3% v/v with an exposure time of 60 min (7). This tolerance to use concentrations of hydrogen peroxide has been attributed to the presence of several enzymes such as catalase (7). H. pylori is an uncommon bacterium, however, because it is only found in the human stomach.

On the other hand, Bacillus subtilis mutants (MBC = 0.5%) are more resistant to hydrogen peroxide than wild strains are (MBC = 0.34%) (8). This example shows that "resistant" means having reduced susceptibility. Mutant B. subtilis is still killed by hydrogen peroxide at use concentrations.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
38%
Breakthrough designations
13%
Protecting the supply chain
38%
Expedited reviews of drug submissions
13%
More stakeholder involvement
0%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
USP Faces New Challenges
Source: Pharmaceutical Technology,
Click here